| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hypertension, Pulmonary | D006976 | 32 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Hypertrophy, Right Ventricular | D017380 | 4 associated lipids |
Total
4
14,15-dihetre
14,15-dihetre is a lipid of Fatty Acyls (FA) class.
Cross Reference
There are no associated biomedical information in the current reference collection.
Current reference collection contains 204 references associated with 14,15-dihetre in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.
Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.
Here are additional resources we collected from PubChem and MeSH for 14,15-dihetre
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with 14,15-dihetre
PubChem Biomolecular Interactions and Pathways
NCBI Entrez Crosslinks
All references with 14,15-dihetre
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Fang X et al. | 14,15-Epoxyeicosatrienoic acid inhibits prostaglandin E2 production in vascular smooth muscle cells. | 1998 | Am. J. Physiol. | pmid:9843811 |
| Oltman CL et al. | Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. | 1998 | Circ. Res. | pmid:9797342 |
| Fang X et al. | Cytochrome P450 metabolites of arachidonic acid: rapid incorporation and hydration of 14,15-epoxyeicosatrienoic acid in arterial smooth muscle cells. | 1997 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:9430380 |
| Nithipatikom K et al. | Determination of 14,15-epoxyeicosatrienoic acid and 14,15-dihydroxyeicosatrienoic acid by fluoroimmunoassay. | 1997 | Anal. Biochem. | pmid:9073364 |
| pmid:28958841 | ||||
| pmid:27663770 | ||||
| Zhang K et al. | Apocynin improving cardiac remodeling in chronic renal failure disease is associated with up-regulation of epoxyeicosatrienoic acids. | 2015 | Oncotarget | pmid:26322503 |
| Zhang S et al. | CYP2J2 overexpression ameliorates hyperlipidemia via increased fatty acid oxidation mediated by the AMPK pathway. | 2015 | Obesity (Silver Spring) | pmid:26053032 |
| Nelson JW et al. | Role of soluble epoxide hydrolase in age-related vascular cognitive decline. | 2014 | Prostaglandins Other Lipid Mediat. | pmid:25277097 |
| Chen W et al. | CYP2J2 and EETs Protect against Oxidative Stress and Apoptosis in Vivo and in Vitro Following Lung Ischemia/Reperfusion. | 2014 | Cell. Physiol. Biochem. | pmid:24903033 |
| Yang T et al. | The role of 14,15-dihydroxyeicosatrienoic acid levels in inflammation and its relationship to lipoproteins. | 2013 | Lipids Health Dis | pmid:24148690 |
| Podolin PL et al. | In vitro and in vivo characterization of a novel soluble epoxide hydrolase inhibitor. | 2013 Jul-Aug | Prostaglandins Other Lipid Mediat. | pmid:23434473 |
| Nelson JW et al. | Soluble epoxide hydrolase dimerization is required for hydrolase activity. | 2013 | J. Biol. Chem. | pmid:23362272 |
| Chen L et al. | Beneficial effects of inhibition of soluble epoxide hydrolase on glucose homeostasis and islet damage in a streptozotocin-induced diabetic mouse model. | 2013 Jul-Aug | Prostaglandins Other Lipid Mediat. | pmid:23247129 |
| Oni-Orisan A et al. | Dual modulation of cyclooxygenase and CYP epoxygenase metabolism and acute vascular inflammation in mice. | 2013 Jul-Aug | Prostaglandins Other Lipid Mediat. | pmid:23000418 |
| Strauss KI et al. | Altered behavioral phenotypes in soluble epoxide hydrolase knockout mice: effects of traumatic brain injury. | 2013 Jul-Aug | Prostaglandins Other Lipid Mediat. | pmid:22922090 |
| Chaudhary KR et al. | Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice. | 2013 Jul-Aug | Prostaglandins Other Lipid Mediat. | pmid:22922020 |
| Anwar-Mohamed A et al. | Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart. | 2012 | Xenobiotica | pmid:22680237 |
| Theken KN et al. | Evaluation of cytochrome P450-derived eicosanoids in humans with stable atherosclerotic cardiovascular disease. | 2012 | Atherosclerosis | pmid:22503544 |
| Zhao G et al. | Delivery of AAV2-CYP2J2 protects remnant kidney in the 5/6-nephrectomized rat via inhibition of apoptosis and fibrosis. | 2012 | Hum. Gene Ther. | pmid:22260463 |